Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H40O9 |
Molecular Weight | 532.6225 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 13 / 13 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H](CC[C@]34O)C5=CC(=O)OC5)[C@]1(C[C@@]6([H])O[C@@]7(O)[C@@H](O)C[C@@H](C)O[C@@]7([H])O[C@]6([H])C2)C=O
InChI
InChIKey=OWPWFVVPBYFKBG-NYVHBPEFSA-N
InChI=1S/C29H40O9/c1-15-9-23(31)29(34)25(36-15)37-21-11-17-3-4-20-19(27(17,14-30)12-22(21)38-29)5-7-26(2)18(6-8-28(20,26)33)16-10-24(32)35-13-16/h10,14-15,17-23,25,31,33-34H,3-9,11-13H2,1-2H3/t15-,17+,18-,19+,20-,21-,22-,23+,25+,26-,27-,28+,29+/m1/s1
Molecular Formula | C29H40O9 |
Molecular Weight | 532.6225 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 13 / 13 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24644251Curator's Comment: description was created based on several sources, including:
http://www.avpayurveda.com/dmdocuments/AMJ%2090.10.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27498029 | https://www.ncbi.nlm.nih.gov/pubmed/14224519
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24644251
Curator's Comment: description was created based on several sources, including:
http://www.avpayurveda.com/dmdocuments/AMJ%2090.10.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27498029 | https://www.ncbi.nlm.nih.gov/pubmed/14224519
Calotropin is an pharmacologically active compound isolated from Asclepias curasavica L. Whereas calotropin possesses cytotoxicity against several cancer cells, the mechanisms of action remain unclear. Calotropin inhibits the Wnt signaling pathway by increasing CK1α protein levels.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0030178 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24644251 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22557704
Calotropin was administered through gavage 25 mg/kg body wt. each day for a period of 30 days to male gerbils and rabbits
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27498029
The inhibitory effects of Calotropin on the viability of A549 and A549/ CDDP cells were determined by MTT assay. A549/CDDP cells were significantly inhibited by Calotropin in a concentration-dependent manner with an IC50 of 0.33 ± 0.06 uM at 48 h.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:04:19 GMT 2023
by
admin
on
Sat Dec 16 09:04:19 GMT 2023
|
Record UNII |
3XK21U1BZS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3470
Created by
admin on Sat Dec 16 09:04:19 GMT 2023 , Edited by admin on Sat Dec 16 09:04:19 GMT 2023
|
PRIMARY | |||
|
m2992
Created by
admin on Sat Dec 16 09:04:19 GMT 2023 , Edited by admin on Sat Dec 16 09:04:19 GMT 2023
|
PRIMARY | Merck Index | ||
|
1986-70-5
Created by
admin on Sat Dec 16 09:04:19 GMT 2023 , Edited by admin on Sat Dec 16 09:04:19 GMT 2023
|
PRIMARY | |||
|
16142
Created by
admin on Sat Dec 16 09:04:19 GMT 2023 , Edited by admin on Sat Dec 16 09:04:19 GMT 2023
|
PRIMARY | |||
|
DTXSID10173613
Created by
admin on Sat Dec 16 09:04:19 GMT 2023 , Edited by admin on Sat Dec 16 09:04:19 GMT 2023
|
PRIMARY | |||
|
Calotropin
Created by
admin on Sat Dec 16 09:04:19 GMT 2023 , Edited by admin on Sat Dec 16 09:04:19 GMT 2023
|
PRIMARY | |||
|
3XK21U1BZS
Created by
admin on Sat Dec 16 09:04:19 GMT 2023 , Edited by admin on Sat Dec 16 09:04:19 GMT 2023
|
PRIMARY | |||
|
143925
Created by
admin on Sat Dec 16 09:04:19 GMT 2023 , Edited by admin on Sat Dec 16 09:04:19 GMT 2023
|
PRIMARY |